242 related articles for article (PubMed ID: 20117291)
1. A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.
Thotala DK; Geng L; Dickey AK; Hallahan DE; Yazlovitskaya EM
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):557-65. PubMed ID: 20117291
[TBL] [Abstract][Full Text] [Related]
2. A GSK-3β inhibitor protects against radiation necrosis in mouse brain.
Jiang X; Perez-Torres CJ; Thotala D; Engelbach JA; Yuan L; Cates J; Gao F; Drzymala RE; Rich KM; Schmidt RE; Ackerman JJ; Hallahan DE; Garbow JR
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):714-21. PubMed ID: 24969790
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
4. Lenticular mitoprotection. Part B: GSK-3β and regulation of mitochondrial permeability transition for lens epithelial cells in atmospheric oxygen.
Brooks MM; Neelam S; Cammarata PR
Mol Vis; 2013; 19():2451-67. PubMed ID: 24319338
[TBL] [Abstract][Full Text] [Related]
5. GSK-3β inhibition attenuates LPS-induced death but aggravates radiation-induced death via down-regulation of IL-6.
Li B; Zhang C; He F; Liu W; Yang Y; Liu H; Liu X; Wang J; Zhang L; Deng B; Gao F; Cui J; Liu C; Cai J
Cell Physiol Biochem; 2013; 32(6):1720-8. PubMed ID: 24356466
[TBL] [Abstract][Full Text] [Related]
6. GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line.
Dickey A; Schleicher S; Leahy K; Hu R; Hallahan D; Thotala DK
J Neurooncol; 2011 Aug; 104(1):145-53. PubMed ID: 21161565
[TBL] [Abstract][Full Text] [Related]
7. Lenticular mitoprotection. Part A: Monitoring mitochondrial depolarization with JC-1 and artifactual fluorescence by the glycogen synthase kinase-3β inhibitor, SB216763.
Brooks MM; Neelam S; Fudala R; Gryczynski I; Cammarata PR
Mol Vis; 2013; 19():1406-12. PubMed ID: 23825920
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting glycogen synthase kinase-3 mitigates the hematopoietic acute radiation syndrome in mice.
Lee CL; Lento WE; Castle KD; Chao NJ; Kirsch DG
Radiat Res; 2014 May; 181(5):445-51. PubMed ID: 24720754
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.
Thotala DK; Hallahan DE; Yazlovitskaya EM
Cancer Res; 2008 Jul; 68(14):5859-68. PubMed ID: 18632640
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells.
Tan J; Zhuang L; Leong HS; Iyer NG; Liu ET; Yu Q
Cancer Res; 2005 Oct; 65(19):9012-20. PubMed ID: 16204075
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3beta regulates differentiation-induced apoptosis of human neural progenitor cells.
Jaeger A; Baake J; Weiss DG; Kriehuber R
Int J Dev Neurosci; 2013 Feb; 31(1):61-8. PubMed ID: 23085082
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
Kaga S; Zhan L; Altaf E; Maulik N
J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
[TBL] [Abstract][Full Text] [Related]
14. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2014; 20():1758-75. PubMed ID: 25593505
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting glycogen synthase kinase 3beta in sepsis.
Dugo L; Collin M; Allen DA; Patel NS; Bauer I; Mervaala E; Louhelainen M; Foster SJ; Yaqoob MM; Thiemermann C
Novartis Found Symp; 2007; 280():128-42; discussion 142-6, 160-4. PubMed ID: 17380792
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
Wu W; Liu X; Han L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3β inhibitors protect hippocampal neurons from radiation-induced apoptosis by regulating MDM2-p53 pathway.
Thotala DK; Hallahan DE; Yazlovitskaya EM
Cell Death Differ; 2012 Mar; 19(3):387-96. PubMed ID: 21738215
[TBL] [Abstract][Full Text] [Related]
19. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat.
Dugo L; Collin M; Allen DA; Patel NS; Bauer I; Mervaala EM; Louhelainen M; Foster SJ; Yaqoob MM; Thiemermann C
Crit Care Med; 2005 Sep; 33(9):1903-12. PubMed ID: 16148458
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
